Clinical trial · Interventional
Efficacy Study of Acupuncture to Treat the Upper Abdominal Pain of Cancer Patients
Pilot Study of Acupuncture to Alleviate the Upper Abdominal Pain of Cancer Patients Treated With Neurolytic Celiac Plexus Block
NCT01913574CI-TRIAL-00055633completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is to investigate the effectiveness of acupuncture for alleviating the upper abdominal pain of cancer patients
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Abdominal Pain | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acupuncture | Device | — | UNRESOLVED |
| Neurolytic celiac plexus block (NCPB) | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Acupuncture & NCPB
- description
- The NCPB will be administered once at the start of the trial and the acupuncture will be performed 3 times per week for 2 weeks (6 times in total).
- interventionNames
- Device: Acupuncture
- Procedure: Neurolytic celiac plexus block (NCPB)
- type
- ACTIVE_COMPARATOR
- label
- NCPB
- description
- The NCPB alone will be applied to the patients in this group, once at the start of the trial.
- interventionNames
- Procedure: Neurolytic celiac plexus block (NCPB)
Primary outcomes (1)
- measure
- Visual analogue scale(VAS)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Age over 18 years * Upper abdominal pain VAS ≥ 5 * Unresectable abdominal malignancy, moderate or severe abdominal pain poorly controlled with pharmacotherapy. * All patients had advanced cancer diagnosed by histological/cytological examination * Follow-up possible during the clinical trial * Written informed consent voluntarily Exclusion Criteria: * Patient with uncorrectable coagulopathy * Patient with allergy to local anesthesics or alcohol.. * Previous NCPB or had implanted epidural or intrathecal analgesic therapy * Inability to lie prone * Disease encasing the celiac plexus on computed Tomography scan * Patients with psychiatric diseases that could have affected the study assessments * Significant renal or hepatic disease * Inability to comprehend or express oneself in the Korean language * Refusal to participate in the trial or to provide informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.